Whooping cough vaccines provide strong protection for the first few years, but immunity fades faster than most people expect. After the childhood series, about 65% of children remain immune at the five-year mark. After an adult booster, protection likely lasts around 10 years, which is why a booster every decade is the standard recommendation. The exact timeline depends on which vaccines you received, your age, and whether you’re protecting yourself or a newborn.
Protection After the Childhood Series
Children in the U.S. receive five doses of the DTaP vaccine, finishing around age 4 to 6. In the first year after that final dose, effectiveness sits around 80%. It stays above 75% through ages 5 to 9, then drops more noticeably into the preteen years. By five years after the last dose, roughly 65% of children still have meaningful protection. That steady decline is a major reason preteens are scheduled for a booster at age 11 or 12.
The drop-off is significant enough that outbreaks in highly vaccinated communities tend to cluster among older children and adolescents, the group furthest from their last dose. Vaccination still reduces the severity of illness if a child does catch whooping cough, but the window of strong protection is narrower than many parents assume.
How Long the Adult Booster Lasts
The Tdap booster given to preteens, teens, and adults provides solid protection for at least five years, based on studies tracking antibody levels and immune cell responses that far out. The pattern of slow antibody decline suggests protection extends to roughly 10 years, though it weakens gradually rather than shutting off at a fixed point. One Canadian study found that effectiveness dropped to about 41% after eight or more years.
The current CDC schedule reflects this timeline: one dose of Tdap, then a booster (Td or Tdap) every 10 years. Pregnant women are a special case and should get a dose during each pregnancy, ideally between weeks 27 and 36.
Why Modern Vaccines Fade Faster
The whooping cough vaccines used today are “acellular,” meaning they contain only a few purified pieces of the bacteria rather than killed whole cells. They cause far fewer side effects than the older whole-cell vaccines used before the late 1990s, but they also produce a different kind of immune response, one that’s weaker at creating lasting cellular immunity.
The practical difference is striking. Teenagers who received the older whole-cell vaccine as infants had roughly five times lower odds of developing whooping cough compared to teens who got the modern acellular version. People who received even a single dose of whole-cell vaccine in their primary series maintained protection longer than those who received only acellular doses. Studies in animal models have also shown that while acellular vaccines prevent symptoms effectively, they do less to stop people from carrying and spreading the bacteria.
This isn’t a reason to avoid vaccination. The acellular vaccines still prevent severe disease and are much safer in terms of side effects. But it does explain why whooping cough hasn’t disappeared despite high vaccination rates, and why boosters matter more than they used to.
Protection for Newborns
Babies can’t start their own vaccine series until two months old, leaving a vulnerable gap. When a pregnant woman gets Tdap between 27 and 36 weeks of pregnancy, her body produces antibodies that cross the placenta and give the baby a head start. This lowers the risk of whooping cough in babies younger than two months by about 78%. Antibody levels peak roughly two weeks after vaccination, which is why the earlier part of that 27-to-36-week window is preferred.
This passive protection is temporary. Maternal antibodies decline over the baby’s first few months of life, which is why the infant’s own vaccination series begins at two months. Each pregnancy requires a new Tdap dose because the mother’s antibody levels also drop over time.
A “cocooning” strategy, where both parents get vaccinated after the baby is born, offers some additional protection (one study estimated about 64% effectiveness after adjusting for other factors), but it’s less reliable than maternal vaccination during pregnancy. It’s a reasonable backup if the mother didn’t get vaccinated while pregnant, but not a substitute.
What Breakthrough Cases Look Like
When vaccinated people do catch whooping cough, the illness is typically milder. Adults with waning immunity often experience a prolonged cough lasting weeks, sometimes without the classic “whoop” sound. In fact, whooping cough is one of the most common causes of persistent cough in adults, accounting for anywhere from 3% to 32% of prolonged cough cases in developed countries. Many of these people never realize they have it.
School-age children can also carry the bacteria without obvious symptoms, which makes them potential spreaders even when they feel fine. This is especially relevant for families with newborns or elderly relatives, since the people most at risk of severe complications are the very young and the very old.
Practical Timeline at a Glance
- First year after vaccination: roughly 80% effectiveness, the peak window of protection.
- 1 to 5 years after childhood series: protection gradually declines but stays above 65% for most children.
- 5 to 10 years after a booster: protection continues to weaken, dropping to around 41% by year eight or later in some studies.
- Beyond 10 years: protection is minimal, and a new booster is recommended.
- Newborn passive immunity: a few months at most, bridging the gap until the baby’s own vaccines begin.
If you’re unsure when you last had a Tdap booster, it’s worth checking. Many adults are well past the 10-year mark without realizing it, especially if they think of tetanus shots and whooping cough boosters as separate things. They’re the same vaccine.